» Articles » PMID: 9237137

Basic Fibroblast Growth Factor MRNA, BFGF Peptide and FGF Receptor in Epiretinal Membranes of Intraocular Proliferative Disorders (PVR and PDR)

Overview
Journal Int Ophthalmol
Specialty Ophthalmology
Date 1996 Jan 1
PMID 9237137
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Basic fibroblast growth factor (bFGF) has been shown to be involved in epiretinal membrane formation in proliferative vitreoretinal disorders. However, up to now, little knowledge exists; as to the actual cellular source of this potent mitogen. We examined 20 epiretinal membranes from patients with proliferative diabetic retinopathy (PDR) (n = 12) and proliferative vitreoretinopathy (PVR) (n = 8) for the presence of bFGF peptide, fibroblast growth factor receptor-1 (FGFR-1) and bFGF messenger ribonucleic acid (mRNA). Using a specific antibody, we detected bFGF peptide in most (8/10) examined PDR membranes and in all (8/8) PVR membranes. Moreover, we found positive staining for the corresponding receptor. Local production of bFGF in epiretinal membranes was confirmed by nonisotopic in situ hybridisation for bFGF mRNA in some (4/7) examined PDR membranes and some (3/4) examined PVR membranes. All membranes which contained bFGF mRNA were also positive for bFGF peptide. In conclusion, bFGF is produced and stored in epiretinal membranes. Together with the corresponding receptor, bFGF may play a role in the auto- and paracrine control of the proliferative processes at the vitreoretinal interface.

Citing Articles

Müller cells and retinal angiogenesis: critical regulators in health and disease.

Medina-Arellano A, Albert-Garay J, Medina-Sanchez T, Fonseca K, Ruiz-Cruz M, Ochoa-de la Paz L Front Cell Neurosci. 2024; 18:1513686.

PMID: 39720707 PMC: 11666533. DOI: 10.3389/fncel.2024.1513686.


Eye on the horizon: The metabolic landscape of the RPE in aging and disease.

Hansman D, Du J, Casson R, Peet D Prog Retin Eye Res. 2024; 104:101306.

PMID: 39433211 PMC: 11833275. DOI: 10.1016/j.preteyeres.2024.101306.


Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy.

Huang Z, Chen L, Huang D, Yi J, Chen Z, Lin P J Diabetes Res. 2024; 2024:2550367.

PMID: 39308630 PMC: 11416173. DOI: 10.1155/2024/2550367.


Pathophysiology and clinical aspects of epiretinal membrane - review.

Ozog M, Nowak-Was M, Rokicki W Front Med (Lausanne). 2023; 10:1121270.

PMID: 37636571 PMC: 10447902. DOI: 10.3389/fmed.2023.1121270.


Klotho: A new therapeutic target in diabetic retinopathy?.

Puddu A, Maggi D World J Diabetes. 2023; 14(7):1027-1036.

PMID: 37547589 PMC: 10401458. DOI: 10.4239/wjd.v14.i7.1027.


References
1.
Sternfeld M, Robertson J, Shipley G, Tsai J, Rosenbaum J . Cultured human retinal pigment epithelial cells express basic fibroblast growth factor and its receptor. Curr Eye Res. 1989; 8(10):1029-37. DOI: 10.3109/02713688908997395. View

2.
Root L, Shipley G . Human dermal fibroblasts express multiple bFGF and aFGF proteins. In Vitro Cell Dev Biol. 1991; 27A(10):815-22. DOI: 10.1007/BF02631248. View

3.
Zhang Y, Tatsuno T, Carney J, Mattson M . Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cereb Blood Flow Metab. 1993; 13(3):378-88. DOI: 10.1038/jcbfm.1993.51. View

4.
Senior R, Huang S, Griffin G, Huang J . Brain-derived growth factor is a chemoattractant for fibroblasts and astroglial cells. Biochem Biophys Res Commun. 1986; 141(1):67-72. DOI: 10.1016/s0006-291x(86)80335-7. View

5.
Weller M, Wiedemann P, Heimann K . Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?. Int Ophthalmol. 1990; 14(2):105-17. DOI: 10.1007/BF00154210. View